In response to industry demand, RoslinCT and Lykan Bioscience, a Contract Development and Manufacturing company for cell therapies, unveiled six new cGMP processing suites to their facility in Hopkinton, MA. The completion of the expansion brings the global capacity to 22 cGMP suites with 14 in Hopkinton, and another eight in Edinburgh, Scotland. The new processing suites will range from 105 to 525 square feet, including specific suites designed to meet both U.S. and EU regulatory requirem...